Evidence map›Paper›PMID 38282012›Full record

ArticleScientific reports2024

Next generation phenotyping for diagnosis and phenotype-genotype correlations in Kabuki syndrome.

Quentin Hennocq, Marjolaine Willems, Jeanne Amiel, Stéphanie Arpin, Tania Attie-Bitach, Thomas Bongibault, Thomas Bouygues, Valérie Cormier-Daire, Pierre Corre, Klaus Dieterich and 15 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. AI-Based Facial Phenotyping Supports a Shared Molecular Axis inInternational journal of molecular sciences · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Humanitarian Facial Recognition for Rare Craniofacial Malformations.Plastic and reconstructive surgery. Global open · 2024
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 3 countries.

Quentin HennocqImagine Institute, INSERM UMR1163, 75015, Paris, France. quentin.hennocq@aphp.fr.ORCID http://orcid.org/0000-0001-7882-8287
Marjolaine WillemsDépartement de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier University, Montpellier, France.
Jeanne AmielImagine Institute, INSERM UMR1163, 75015, Paris, France.
Stéphanie ArpinService de Génétique, CHU Tours, UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
Tania Attie-BitachImagine Institute, INSERM UMR1163, 75015, Paris, France.
Thomas BongibaultImagine Institute, INSERM UMR1163, 75015, Paris, France.
Thomas BouyguesImagine Institute, INSERM UMR1163, 75015, Paris, France.
Valérie Cormier-DaireImagine Institute, INSERM UMR1163, 75015, Paris, France.
Pierre CorreNantes Université, CHU Nantes, Service de chirurgie maxillo-faciale et stomatologie, 44000, Nantes, France.
Klaus DieterichUniv. Grenoble Alpes, Inserm, U1209, IAB, CHU Grenoble Alpes, 38000, Grenoble, France.
Maxime DouilletImagine Institute, INSERM UMR1163, 75015, Paris, France.
Jean FeydyHeKA team, INRIA, 75012, Paris, France.
Eva GallianiService de chirurgie maxillo-faciale et chirurgie plastique, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Fabienne GiulianoMEDISYN Genetics, Lausanne, Switzerland.
Stanislas LyonnetImagine Institute, INSERM UMR1163, 75015, Paris, France.
Arnaud PicardService de chirurgie maxillo-faciale et chirurgie plastique, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Thantrira PorntaveetusCenter of Excellence in Genomics and Precision Dentistry, Department of Physiology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
Marlène RioImagine Institute, INSERM UMR1163, 75015, Paris, France.
Flavien RouxelDépartement de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier University, Montpellier, France.
Vorasuk ShotelersukCenter of Excellence for Medical Genomics, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Annick ToutainService de Génétique, CHU Tours, UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
Kevin YauyDépartement de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier University, Montpellier, France.
David Geneviève *Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Génétique clinique, CHU Montpellier, Centre de référence anomalies du développement SOOR, INSERM U1183, Montpellier University, Montpellier, France.
Roman H Khonsari *Imagine Institute, INSERM UMR1163, 75015, Paris, France.
Nicolas GarcelonImagine Institute, INSERM UMR1163, 75015, Paris, France.
Hôpital Necker-Enfants Malades · FRInserm · FRChulalongkorn University · THUniversité de Tours · FRDélégation Paris 5 · FRInstitut national de recherche en sciences et technologies du numérique · FR

Funding

Agence Nationale de la Recherche ANR-10-IAHU-01Thailand Science Research and Innovation N42A650229
6 · The paper itself

Abstract

The field of dysmorphology has been changed by the use Artificial Intelligence (AI) and the development of Next Generation Phenotyping (NGP). The aim of this study was to propose a new NGP model for predicting KS (Kabuki Syndrome) on 2D facial photographs and distinguish KS1 (KS type 1, KMT2D-related) from KS2 (KS type 2, KDM6A-related). We included retrospectively and prospectively, from 1998 to 2023, all frontal and lateral pictures of patients with a molecular confirmation of KS. After automatic preprocessing, we extracted geometric and textural features. After incorporation of age, gender, and ethnicity, we used XGboost (eXtreme Gradient Boosting), a supervised machine learning classifier. The model was tested on an independent validation set. Finally, we compared the performances of our model with DeepGestalt (Face2Gene). The study included 1448 frontal and lateral facial photographs from 6 centers, corresponding to 634 patients (527 controls, 107 KS); 82 (78%) of KS patients had a variation in the KMT2D gene (KS1) and 23 (22%) in the KDM6A gene (KS2). We were able to distinguish KS from controls in the independent validation group with an accuracy of 95.8% (78.9-99.9%, p < 0.001) and distinguish KS1 from KS2 with an empirical Area Under the Curve (AUC) of 0.805 (0.729-0.880, p < 0.001). We report an automatic detection model for KS with high performances (AUC 0.993 and accuracy 95.8%). We were able to distinguish patients with KS1 from KS2, with an AUC of 0.805. These results outperform the current commercial AI-based solutions and expert clinicians.

Indexed as

Abnormalities, MultipleArtificial IntelligenceHematologic DiseasesVestibular DiseasesFaceGenotypeHistone DemethylasesHumansMutationPhenotypeRetrospective StudiesHistone Demethylases

Identifiers

PMID38282012
PMCPMC10822856
OpenAlexW4391288921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.